DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
about
TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavagesDLC-1: a Rho GTPase-activating protein and tumour suppressorAberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2 '-deoxycytidineDLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanismsThe Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasisThe phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liverInhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell linesApproaches of targeting Rho GTPases in cancer drug discoveryDeleted in liver cancer-1 (DLC1): an emerging metastasis suppressor geneTranscriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancerIdentification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cellsDLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaDLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activityA novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumorsThe role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancerDeleted in liver cancer protein family in human malignancies (Review)Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cellsCRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growthROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasionDLC1: a significant GAP in the cancer genomeRole of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motilityDLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domainIdentification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoformMetastasis suppressor genes at the interface between the environment and tumor cell growthDownregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progressionPilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinomaDLC1 is the principal biologically-relevant down-regulated DLC family member in several cancersEvaluation of surface water quality indices and ecological risk assessment for heavy metals in scrap yard neighbourhoodIdentification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphomaDeleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinomaHigh-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivoMultiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancerSolution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA.Metastasis suppressors and the tumor microenvironmentIn vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cellsGenomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung
P2860
Q23910293-D52E30A7-4957-45B0-A374-03D2844AED48Q23917637-81689D29-130F-4E26-A75F-5E6017275DD4Q24170503-271C1A9D-36D6-44F1-B264-EF65C6C8085FQ24297480-32C1D145-2CA0-4428-9912-945553D630D2Q24313125-2B12FE17-2285-40E5-8FC5-89C0550C248CQ24338316-27C17384-039D-41A9-B4C9-EEC2145BBCE8Q24645379-EB398B5A-A32F-40FB-9ACD-1B7AC354A51FQ24678585-713F96E9-790F-47CE-B98B-3C0965AF4547Q26851300-475B7C4C-72BB-4041-A7EE-186DADFCB874Q27025409-A54889B7-880B-43DA-A839-842522D2F978Q28260824-1356868A-0244-4531-A00B-EE2D1BC71DDCQ28285843-FC27DCC5-777F-48C7-B285-61FC79FE3C7FQ28384558-079F0D34-CF96-4F7C-B8F8-613198A1147AQ28385400-3C9D9524-FF65-4DE6-80B8-0F1008445529Q28385864-DBCC3DFD-9EB0-42B2-817C-CCBAA89D0FA6Q28386116-8F80F438-C18F-4155-9875-F32A74FA68FFQ28387011-CE804CED-74A9-4FDB-B9B7-41A53B4D5C1BQ28388574-DAF3E6F6-0515-40E7-A299-B50E7D88A5D4Q28389945-6363BB34-5F05-4BE4-B8EA-D6D0379058E4Q28390371-08D2EA16-F5B5-417F-B463-1ECC6635F65EQ28390592-A9E5C8B7-3011-4E5D-A2C3-F6CF5714B81CQ28391398-1235ACFD-F6C5-4A0D-9BDE-1A7BADDF0615Q28391564-99BB34CE-EB9D-45CC-8E9F-8C2D41EBBFDBQ28394290-A1064302-5CB7-4251-8A31-6D6BF98856AEQ28394526-3EFC0EE1-B20B-4F39-9F33-EA582311A2FEQ28395305-01138E43-3130-4C88-B85D-C50BC1BA29A6Q28395522-C42A95D2-F4F3-4583-AE26-CEA6AB228754Q28397799-CBCEAC69-5322-46DA-82CE-ADED306861DFQ28603262-DAE34E0D-F1B0-435C-80C7-11155081181EQ30447293-C59143D2-D550-4ADA-9EF3-0F8C3182D485Q30884853-86FFD1B7-F7AC-4390-AF9A-7F837E56DBABQ33354161-4B1F30AC-63F2-4C5E-B9B8-0E10C9CE4CFEQ33629786-212A959E-095C-40D9-BE36-46AA9E84761DQ34038402-0A9F4333-E79A-4BC9-A9D8-B64F31B4F6D4Q34202639-8E2F6143-93D4-4E4A-8808-87AE484F08B4Q34285684-89AE4584-BE9D-4AC5-B256-73ADE2EF63ADQ34499924-2DE75A21-3E24-4969-8518-EA673F169956Q34648929-846298FF-A3B4-4755-8225-14A864D109D2Q34680671-10F50207-A9A8-4C7A-A610-BF0B2B855AECQ34795438-016E077A-B715-4630-A9AA-0203BFB11A05
P2860
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@ast
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en-gb
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@nl
type
label
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@ast
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en-gb
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@nl
prefLabel
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@ast
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en-gb
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@nl
P2093
P2860
P3181
P356
P1433
P1476
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
@en
P2093
Amy M Jefferson
Bao-Zhu Yuan
Kimberly T Baldwin
Nicholas C Popescu
Snorri S Thorgeirsson
P2860
P2880
P2888
P304
P3181
P356
10.1038/SJ.ONC.1207291
P407
P577
2003-12-08T00:00:00Z
P5875
P6179
1003827126